Adding mirabegron after intravesical onabotulinumtoxinA injection improves therapeutic effects in patients with refractory overactive bladder.

Cheng-Chung Wang Cheng-Ling LeeYi-Ting HwangHann-Chorng Kuo

Published in: Lower urinary tract symptoms (2021)

Adding mirabegron could increase the therapeutic effects, mainly on OAB symptoms and GRA scale, after intravesical onabotulinumtoxinA injection in refractory OAB patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
ultrasound guided
muscle invasive bladder cancer
depressive symptoms
physical activity
sleep quality